Ellen Puré
6Patents
1h-index
8Co-inventors
36Inventor score
Filing activity: Sep 30, 2013 → Sep 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9365641B2 | Compositions and methods for targeting stromal cells for the treatment of cancer | Chemistry; Metallurgy | 42 | Active |
| US11718685B2 | Compositions and methods for targeting stromal cells for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11786551B2 | Methods for treating heart disease via redirected T cell immunotherapies | Chemistry; Metallurgy | 0 | Active |
| US10329355B2 | Compositions and methods for targeting stromal cells for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US12139550B2 | Monoclonal antibody against canine fibroblast activation protein that cross-reacts with mouse and human fibroblast activation protein (FAP) | Physics | 0 | Active |
| US12116418B2 | Disrupting tumor tissues by targeting fibroblast activation protein (FAP) | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.